A multicenter, randomized, double-blind study of the antihypertensive efficacy and tolerability of Irbesartan in patients aged ≥65 years with mild to moderate hypertensionLACOURCIERE, Yves.Clinical therapeutics. 2000, Vol 22, Num 10, pp 1213-1224, issn 0149-2918Article

Antihypertensive effects of two fixed-dose Combinations of losartan and hydrochlorothiazide versus hydrochlorothiazide monotherapy in subjects with ambulatory systolic hypertensionLACOURCIERE, Yves; POIRIER, Luc.American journal of hypertension. 2003, Vol 16, Num 12, pp 1036-1042, issn 0895-7061, 7 p.Article

Effects of nebivolol and atenolol on insulin sensitivity and haemodynamics in hypertensive patientsPOIRIER, Luc; CLEROUX, Jean; NADEAU, André et al.Journal of hypertension. 2001, Vol 19, Num 8, pp 1429-1435, issn 0263-6352Article

Effects of the angiotensin II receptor blockers telmisartan versus valsartan on the circadian variation of blood pressure impact on the early morning periodWHITE, William B; LACOURCIERE, Yves; DAVIDAI, Giora et al.American journal of hypertension. 2004, Vol 17, Num 4, pp 347-353, issn 0895-7061, 7 p.Article

Methodology to determine duration of action for antihypertensive drugsLEFEBVRE, Jean; POIRIER, Luc; LACOURCIERE, Yves et al.The Annals of pharmacotherapy. 2002, Vol 36, Num 5, pp 874-881, issn 1060-0280Article

Comparison of fixed-dose combinations of telmisartan/ hydrochlorothiazide 40/12.5 mg and 80/12.5 mg and a fixed-dose combination of losartan/hydrochlorothiazide 50/12.5 mg in mild to moderate essential hypertension : Pooled analysis of two multicenter, prospective, randomized, open-label, blinded-end point (PROBE) trialsLACOURCIERE, Yves; NEUTEL, Joel M; SCHUMACHER, Helmut et al.Clinical therapeutics. 2005, Vol 27, Num 11, pp 1795-1805, issn 0149-2918, 11 p.Article

The influence of CYP2D6 phenotype on the clinical response of nebivolol in patients with essential hypertensionLEFEBVRE, Jean; POIRIER, Luc; POIRIER, Paul et al.British journal of clinical pharmacology. 2007, Vol 63, Num 5, pp 575-582, issn 0306-5251, 8 p.Article

A new approach to assessing antihypertensive therapy: effect of treatment on pulse pressureASMAR, Roland; LACOURCIERE, Yves.Journal of hypertension. 2000, Vol 18, Num 11, pp 1683-1690, issn 0263-6352Article

Effects of mild exercise on insulin sensitivity in hypertensive subjectsRHEAUME, Caroline; WAIB, Paulo H; LACOURCIERE, Yves et al.Hypertension (Dallas, Tex. 1979). 2002, Vol 39, Num 5, pp 989-995, issn 0194-911XArticle

Effects of demographics on the antihypertensive efficacy of triple therapy with amlodipine, valsartan, and hydrochlorothiazide for moderate to severe hypertensionCALHOUN, David A; LACOURCIERE, Yves; CRIKELAIR, Nora et al.Current medical research and opinion. 2013, Vol 29, Num 8, pp 901-910, issn 0300-7995, 10 p.Article

Antihypertensive efficacy and tolerability of two fixed- dose combinations of valsartan and hydrochlorothiazide compared with valsartan monotherapy in patients with stage 2 or 3 systolic hypertension : An 8-week, randomized, double-blind, parallel-group trialLACOURCIERE, Yves; POIRIER, Luc; HEBERT, Daniel et al.Clinical therapeutics. 2005, Vol 27, Num 7, pp 1013-1021, issn 0149-2918, 9 p.Article

Effects of circadian rhythms, posture, and medication on renin-aldosterone interrelations in essential hypertensivesLAMARRE-CLICHE, Maxime; DE CHAMPLAIN, Jacques; LACOURCIERE, Yves et al.American journal of hypertension. 2005, Vol 18, Num 1, pp 56-64, issn 0895-7061, 9 p.Article

Blood-pressure reduction with LCZ696, a novel dual-acting inhibitor of the angiotensin II receptor and neprilysin: a randomised, double-blind, placebo-controlled, active comparator studyRUILOPE, Luis Miguel; DUKAT, Andrej; BOHM, Michael et al.Lancet (British edition). 2010, Vol 375, Num 9722, pp 1255-1266, issn 0140-6736, 12 p.Article

Effects of graded-release diltiazem versus ramipril, dosed at bedtime, on early morning blood pressure, heart rate, and the rate-pressure productWHITE, William B; LACOURCIERE, Yves; GANA, Theophilus et al.The American heart journal. 2004, Vol 148, Num 4, pp 628-634, issn 0002-8703, 7 p.Article

Prospective, randomized, open-label, blinded-endpoint (PROBE) designed trials yield the same results as double-blind, placebo-controlled trials with respect to ABPM measurements. CommentaryPARATI, Gianfranco; STAESSEN, Jan A; SMITH, David H. G et al.Journal of hypertension. 2003, Vol 21, Num 7, pp 1237-1239, issn 0263-6352, 11 p.Article

Triple Antihypertensive Therapy With Amlodipine, Valsartan, and Hydrochlorothiazide: A Randomized Clinical TrialCALHOUN, David A; LACOURCIERE, Yves; YANN TONG CHIANG et al.Hypertension (Dallas, Tex. 1979). 2009, Vol 54, Num 1, pp 32-39, issn 0194-911X, 8 p.Article

A multicenter, 14-week study of telmisartan and ramipril in patients with mild-to-moderate hypertension using ambulatory blood pressure monitoringLACOURCIERE, Yves; NEUTEL, Joel M; DAVIDAI, Gloria et al.American journal of hypertension. 2006, Vol 19, Num 1, pp 104-112, issn 0895-7061, 9 p.Article

Effect of Intensive Versus Standard Blood Pressure Lowering on Diastolic Function in Patients With Uncontrolled Hypertension and Diastolic DysfunctionSOLOMON, Scott D; VERMA, Anil; ROCHA, Ricardo et al.Hypertension (Dallas, Tex. 1979). 2010, Vol 55, Num 2, pp 241-248, issn 0194-911X, 8 p.Article

Aortic Diameter, Wall Stiffness, and Wave Reflection in Systolic Hypertension. CommentaryVASAN, Ramachandran S; MITCHELL, Gary F; CONLIN, Paul R et al.Hypertension (Dallas, Tex. 1979). 2008, Vol 51, Num 1, issn 0194-911X, 33-36, 105-111 [11 p.]Article

Determinants of elevated pulse pressure in middle-aged and older subjects with uncomplicated systolic hypertension: The role of proximal aortic diameter and the aortic pressure-flow relationshipMITCHELL, Gary F; LACOURCIERE, Yves; OUELLET, Jean-Pascal et al.Circulation (New York, N.Y.). 2003, Vol 108, Num 13, pp 1592-1598, issn 0009-7322, 7 p.Article

Effects of intense and prolonged exercise on insulin sensitivity and glycogen metabolism in hypertensive subjectsRHEAUME, Caroline; WAIB, Paulo-Henrique; KOUAME, Nguessan et al.Circulation (New York, N.Y.). 2003, Vol 108, Num 21, pp 2653-2659, issn 0009-7322, 7 p.Article

Long-term safety and efficacy of the selective aldosterone blocker eplerenone in patients with essential hypertensionBURGESS, Ellen D; LACOURCIERE, Yves; RUILOPE-URIOSTE, Luis M et al.Clinical therapeutics. 2003, Vol 25, Num 9, pp 2388-2404, issn 0149-2918, 17 p.Article

Paget disease of bone : Mapping of two loci at 5q35-qter and 5q31LAURIN, Jancy; BROWN, Jacques P; LEMAINQUE, Arnaud et al.American journal of human genetics. 2001, Vol 69, Num 3, pp 528-543, issn 0002-9297Article

Changes in aortic stiffness and augmentation index after acute converting enzyme or vasopeptidase inhibitionMITCHELL, Gary F; LACOURCIERE, Yves; ARNOLD, J. Malcolm O et al.Hypertension (Dallas, Tex. 1979). 2005, Vol 46, Num 5, pp 1111-1117, issn 0194-911X, 7 p.Article

Principal results of the controlled onset verapamil investigation of cardiovascular end points (CONVINCE) trialBLACK, Henry R; ELLIOTT, William J; MULLER, James et al.JAMA, the journal of the American Medical Association. 2003, Vol 289, Num 16, pp 2073-2082, issn 0098-7484, 10 p.Article